PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 1, 2022SHILAP Revista de lepidopterología62 citationsOpen Access

ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocol

View Full Paper
AKAntigone KotsakiNational and Kapodistrian University of AthensPPPeter PickkersNortheastern UniversityMBMichael BauerLoyola University Medical Center

Key Points

Key points are not available for this paper at this time.

Abstract

Nct04990232.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Kotsaki et al. (2022) studied this question.

synapsesocial.com/papers/69dff1a71827a1d0b1255518https://doi.org/10.1136/bmjopen-2022-067251
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Monocyte deactivation in septic patients: Restoration by IFN-γ treatment1997 · 1,196 citations
  2. 2Intensive Insulin Therapy and Pentastarch Resuscitation in Severe Sepsis2008 · 2,939 citations
  3. 3Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome2015 · 874 citations
  4. 4Interferon gamma immunotherapy in five critically ill COVID-19 patients with impaired cellular immunity: A case series2021 · 50 citations
  5. 5Sepsis: Current Dogma and New Perspectives2014 · 690 citations